---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-013498"
form_type: "8-K"
ticker: "PLX"
cik: "0001006281"
company_name: "Protalix BioTherapeutics, Inc."
filed_at: "2026-02-11T23:59:59+00:00"
generated_at: "2026-05-16T03:11:52.114225+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.01
calibrated_materiality_score: 0.01
confidence: "low"
source: SEC EDGAR
---

# Protalix BioTherapeutics posts February 2026 corporate presentation to website; no material new data disclosed

## Summary
- Company filed Form 8-K indicating a corporate presentation was posted on February 11, 2026.
- Exhibit 99.1 consists solely of a title slide with no specific financial or pipeline updates.
- No new guidance, clinical data, or business developments were provided in the furnished exhibit.
- Investors would need to access the full presentation on the company website for details.

## SEC filing metadata
- accession: 0001104659-26-013498
- form_type: 8-K
- ticker: PLX
- cik: 0001006281
- company_name: Protalix BioTherapeutics, Inc.
- filed_at: 2026-02-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.01
- calibrated_materiality_score: 0.01
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1006281/000110465926013498/0001104659-26-013498-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1006281/000110465926013498/plx-20260211x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-013498
- JSON: https://secwatch.observer/filing/0001104659-26-013498.json
- Plain text: https://secwatch.observer/filing/0001104659-26-013498.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.